The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes

Obstetrics and Gynecology

Volumn 101, Issue 1, 2003, Pages 123-128

  Sakai, Masatoshi ^a   Sasaki, Yasushi ^a   Yamagishi, Naoko ^a   Tanebe, Kyoko ^a   Yoneda, Satoshi ^a   Saito, Shigeru ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS MONITORING; HOSPITALIZATION; HUMAN; PREDICTION; PREMATURE LABOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERUS BLEEDING; UTERUS CONTRACTION;

EID: 0037222799     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200301000-00024     Document Type: Article

References (18)

1. McCormick M.C. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 312:1985;82-90.
2. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., Sweet R.A. A review of premature birth and clinical infection. Am J Obstet Gynecol. 166:1992;1515-1528.
3. Iams J.D. Current status of prematurity prevention. JAMA. 262:1989;265-266.
4. King J.F., Grant A., Keirse M.J., Chalmers I. Beta-mimetics in preterm labour An overview of the randomized controlled trials . Br J Obstet Gynaecol. 95:1988;211-222.
5. Baumgarten K., Gruber W. Tocolyseindex. Dudenhausen J.W., Saling E. Perinatale Medizin. 1974;197-199 Georg Thieme Verlag, Stuttgart, Germany.
6. Richter R. Evaluation of success in treatment of threatening premature labor by beta mimetic drugs. Am J Obstet Gynecol. 127:1977;482-486.
7. Cunningham F.G., MacDonald P.C., Gant N.F., Leveno K.J., Gilstrap L.C. III. Williams Obstetrics. 19th Ed. Norwalk, Connecticut: Appleton & Lange, 1993;862.
8. Lockwood C.J., Senyei A.E., Dische M.R. Fetal fibronectin in cervical and vaginal secretions defines a patient population at high risk for preterm delivery. N Engl J Med. 325:1991;669-674.
9. Leitich H., Egarter C., Kaider A., Hohlagschwandtner M., Berghammer P., Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery A meta-analysis . Am J Obstet Gynecol. 180:1999;1169-1176.
10. Goepfert A.R., Goldenberg R.L., Mercer B., Iams J., Meis P., Moawad A., et al. The preterm prediction study Quantitative fetal fibronectin values and the prediction of spontaneous preterm birth . Am J Obstet Gynecol. 183:2000;1480-1483.
11. Nelson L.H., Anderson R.L., O'Shea T.M., Swain M. Expectant management of preterm premature rupture of the membranes. Am J Obstet Gynecol. 17:1994;350-358.
12. Irion O., Matute J., Bischof P. Prediction de la prematurite par la fibronectine oncofoetale. J Gynecol Obstet Biol Reprod (Paris). 24:1995;624-629.
13. Burrus D.R., Ernest J.M., Veille J.C. Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idopathic preterm labor. Am J Obstet Gynecol. 173:1995;1258-1262.
14. Morrison J.C., Naef R.W., Botti J.J., Katz M., Belluomini J.M., McLaughlin B.N. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Am J Obstet Gynecol. 87:1996;649-655.
15. Malak T.M., Sizmur F., Bell S.C., Tayler D.J. Fetal fibronectin in cervicovaginal secretions as a predicter of preterm birth. Br J Obstet Gynaecol. 103:1996;648-653.
16. Rinehart B.K., Terrone D.A., Isler C.M., Barrilleaux P.S., Bufkin L., Morrison J.C. Pregnancy outcome in women with preterm labor symptoms without cervical change. Am J Obstet Gynecol. 184:2001;1004-1007.
17. Mauldin J.G., Newman R.B. Preterm birth risk assessment. Semin Perinatol. 25:2001;215-222.
18. Goldenberg R.L., Iams J.D., Mercer B.M., Meis P.J., Moawad A., Das A., et al. The Preterm Prediction Study Toward a multiple-marker test for spontaneous preterm birth . Am J Obstet Gynecol. 185:2001;643-651.